Literature DB >> 18480844

Visualization of targeted transduction by engineered lentiviral vectors.

K-I Joo1, P Wang.   

Abstract

We have reported a method to target lentiviral vectors to specific cell types. This method requires the incorporation of two distinct molecules on the viral vector surface: one is an antibody that renders the targeting specificity for the engineered vector, and the other is a fusogenic protein that allows the engineered vector to enter the target cell. However, the molecular mechanism that controls the targeted infection needs to be defined. In this report, we tracked the individual lentiviral particles by labeling the virus with the GFP-Vpr fusion protein. We were able to visualize the surface-displayed proteins on a single virion as well as antibody-directed targeting to a desired cell type. We also demonstrated the dynamics of virus fusion with endosomes and monitored endosome-associated transport of viruses in target cells. Our results suggest that the fusion between the engineered lentivirus and endosomes takes place at the early endosome level, and that the release of the viral core into the cytosol at the completion of the virus-endosome fusion is correlated with the endosome maturation process. This imaging study sheds some light on the infection mechanism of the engineered lentivirus and can be beneficial to the design of more efficient gene delivery vectors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480844      PMCID: PMC2575058          DOI: 10.1038/gt.2008.87

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  44 in total

Review 1.  Rab proteins as membrane organizers.

Authors:  M Zerial; H McBride
Journal:  Nat Rev Mol Cell Biol       Date:  2001-02       Impact factor: 94.444

Review 2.  Gene therapy: the first decade.

Authors:  A Mountain
Journal:  Trends Biotechnol       Date:  2000-03       Impact factor: 19.536

3.  Localization of low molecular weight GTP binding proteins to exocytic and endocytic compartments.

Authors:  P Chavrier; R G Parton; H P Hauri; K Simons; M Zerial
Journal:  Cell       Date:  1990-07-27       Impact factor: 41.582

4.  Rab conversion as a mechanism of progression from early to late endosomes.

Authors:  Jochen Rink; Eric Ghigo; Yannis Kalaidzidis; Marino Zerial
Journal:  Cell       Date:  2005-09-09       Impact factor: 41.582

5.  Late endosomes derive from early endosomes by maturation.

Authors:  W Stoorvogel; G J Strous; H J Geuze; V Oorschot; A L Schwartz
Journal:  Cell       Date:  1991-05-03       Impact factor: 41.582

6.  The cholesterol requirement for sindbis virus entry and exit and characterization of a spike protein region involved in cholesterol dependence.

Authors:  Y E Lu; T Cassese; M Kielian
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

7.  High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells.

Authors:  H Mochizuki; J P Schwartz; K Tanaka; R O Brady; J Reiser
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

8.  Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells.

Authors:  E J Bowman; A Siebers; K Altendorf
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

9.  Rab7 associates with early endosomes to mediate sorting and transport of Semliki forest virus to late endosomes.

Authors:  Andreas Vonderheit; Ari Helenius
Journal:  PLoS Biol       Date:  2005-06-21       Impact factor: 8.029

10.  Visualization of the intracellular behavior of HIV in living cells.

Authors:  David McDonald; Marie A Vodicka; Ginger Lucero; Tatyana M Svitkina; Gary G Borisy; Michael Emerman; Thomas J Hope
Journal:  J Cell Biol       Date:  2002-11-04       Impact factor: 10.539

View more
  18 in total

1.  Imaging multiple intermediates of single-virus membrane fusion mediated by distinct fusion proteins.

Authors:  Kye-Il Joo; April Tai; Chi-Lin Lee; Clement Wong; Pin Wang
Journal:  Microsc Res Tech       Date:  2010-09       Impact factor: 2.769

Review 2.  Immunization delivered by lentiviral vectors for cancer and infectious diseases.

Authors:  Biliang Hu; April Tai; Pin Wang
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

3.  Engineered lentiviral vectors pseudotyped with a CD4 receptor and a fusogenic protein can target cells expressing HIV-1 envelope proteins.

Authors:  Chi-Lin Lee; Jason Dang; Kye-Il Joo; Pin Wang
Journal:  Virus Res       Date:  2011-07-23       Impact factor: 3.303

4.  Specific retrograde transduction of spinal motor neurons using lentiviral vectors targeted to presynaptic NMJ receptors.

Authors:  I Eleftheriadou; A Trabalza; S M Ellison; K Gharun; N D Mazarakis
Journal:  Mol Ther       Date:  2014-03-26       Impact factor: 11.454

5.  The Vici syndrome protein EPG5 regulates intracellular nucleic acid trafficking linking autophagy to innate and adaptive immunity.

Authors:  E Piano Mortari; V Folgiero; V Marcellini; P Romania; E Bellacchio; V D'Alicandro; C Bocci; R Carrozzo; D Martinelli; S Petrini; E Axiotis; C Farroni; F Locatelli; U Schara; D T Pilz; H Jungbluth; C Dionisi-Vici; R Carsetti
Journal:  Autophagy       Date:  2018-01-02       Impact factor: 16.016

6.  Pseudotyping lentiviral vectors with aura virus envelope glycoproteins for DC-SIGN-mediated transduction of dendritic cells.

Authors:  Steven Froelich; April Tai; Katie Kennedy; Adnan Zubair; Pin Wang
Journal:  Hum Gene Ther       Date:  2011-06-13       Impact factor: 5.695

7.  Targeted gene delivery to CD117-expressing cells in vivo with lentiviral vectors co-displaying stem cell factor and a fusogenic molecule.

Authors:  Steven Froelich; Leslie Ziegler; Katie Stroup; Pin Wang
Journal:  Biotechnol Bioeng       Date:  2009-09-01       Impact factor: 4.530

8.  Gamma-retroviral vectors enveloped with an antibody and an engineered fusogenic protein achieved antigen-specific targeting.

Authors:  Haiguang Yang; Leslie Ziegler; Kye-Il Joo; Taehoon Cho; Yuning Lei; Pin Wang
Journal:  Biotechnol Bioeng       Date:  2008-10-01       Impact factor: 4.530

9.  Cell type-specific targeting with surface-engineered lentiviral vectors co-displaying OKT3 antibody and fusogenic molecule.

Authors:  Haiguang Yang; Kye-Il Joo; Leslie Ziegler; Pin Wang
Journal:  Pharm Res       Date:  2009-03-04       Impact factor: 4.200

10.  Cell-specific targeting of lentiviral vectors mediated by fusion proteins derived from Sindbis virus, vesicular stomatitis virus, or avian sarcoma/leukosis virus.

Authors:  Xian-Yang Zhang; Robert H Kutner; Agnieszka Bialkowska; Michael P Marino; William B Klimstra; Jakob Reiser
Journal:  Retrovirology       Date:  2010-01-25       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.